Organization
Alexza Pharmaceuticals Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Alexza Pharmaceuticals Inc.
... established benzodiazepine." Engage Therapeutics has an exclusive license and supply agreement with Alexza Pharmaceuticals to develop Staccato alprazolam. This novel drug device combination has been ...
... ADASUVE®, an orally inhaled form of the typical antipsychotic loxapine, from Alexza Pharmaceuticals, Inc. ADASUVE is the first and only FDA-approved inhaled therapy for the ...
... in this Insomnia Pipeline Review, H2 2016 report include Actelion Ltd, Alexza Pharmaceuticals, Inc., Eisai Co., Ltd., Evotec AG, Grupo Ferrer Internacional, S.A., Heptares Therapeutics ...
... Seizures Pipeline Review, H2 2016 report include Adamas Pharmaceuticals, Inc., Advicenne, Alexza Pharmaceuticals, Inc., Biscayne Pharmaceuticals, Inc., Catalyst Pharmaceuticals, Inc., Eisai Co., Ltd., GW Pharmaceuticals ...
... Addex Therapeutics Ltd, Advinus Therapeutics Ltd, Aeolus Pharmaceuticals, Inc., AFFiRiS AG, Alexza Pharmaceuticals, Inc., Amabiotics SAS, Amarantus Bioscience Holdings, Inc., American Gene Technologies International Inc., ...
... Alexza Pharmaceuticals, Inc. ("Alexza" or the "Company") today announced that The Nasdaq Stock Market ...
... TARGET COMPANY: 2264403 Alexza Pharmaceuticals Inc. SELLERS: 2264403 Alexza Pharmaceuticals Inc. ACQUIRER COMPANY: 2428624 Ferrer Pharma Inc. ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza", or the "Company") today reported financial results for the ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza", or the "Company") today announced that it intends to ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza") and Grupo Ferrer Internacional, S.A. ("Ferrer") today announced that ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza", or the "Company") will report results for its fiscal ...
... Development of Restless Legs Syndrome and discussed in this research are Alexza Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Ligand Pharmaceuticals, Inc., Mundipharma International Ltd, Omeros ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza", or the "Company") today reported financial results for the ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter and year ended ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza, or the "Company') announced today that on March 7, ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has reacquired U.S. commercial rights for ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that on December 17, 2015, the Company received ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced interim results of its Phase 2a study of ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended September 30, ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it plans to reacquire the U.S. rights ...
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended September 30, ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤